Gainers
- Biohaven Pharma Hldgs BHVN stock moved upwards by 72.6% to $143.49 during Tuesday's pre-market session. The market value of their outstanding shares is at $10.1 billion.
- Evaxion Biotech EVAX shares rose 47.69% to $3.53. The market value of their outstanding shares is at $81.9 million.
- Avenue Therapeutics ATXI shares rose 21.05% to $0.38. The market value of their outstanding shares is at $8.2 million.
- Moleculin Biotech MBRX stock increased by 20.0% to $1.56. The market value of their outstanding shares is at $44.5 million.
- ShockWave Medical SWAV shares moved upwards by 16.46% to $135.0. The market value of their outstanding shares is at $4.8 billion. As per the press release, Q1 earnings came out yesterday.
- Qualigen Therapeutics QLGN stock increased by 14.29% to $0.57. The company's market cap stands at $20.2 million.
Losers
- GoodRx Holdings GDRX stock fell 37.8% to $6.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.6 billion. As per the news, the Q1 earnings report came out yesterday.
- Novavax NVAX shares declined by 22.01% to $41.54. The market value of their outstanding shares is at $3.2 billion. As per the press release, Q1 earnings came out yesterday.
- Blue Water Vaccines BWV stock fell 16.98% to $4.5. The company's market cap stands at $57.6 million.
- Akanda AKAN stock fell 16.16% to $1.92. The company's market cap stands at $55.5 million.
- Vaxart VXRT stock decreased by 14.56% to $2.7. The company's market cap stands at $341.2 million. The company's, Q1 earnings came out yesterday.
- LogicBio Therapeutics LOGC shares fell 11.59% to $0.59. The company's market cap stands at $19.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in